|
Chapter Three
Pure Food and Drug Act
1906
Required manufactures to
indicate the amounts of alcohol, morphine, opium, cocaine, heroin, and marijuana
extract on the label of each product
This gave the consumer the
information necessary to make an informed decision
The Sherley Amendment
Added the requirement to
existing law that labels should not contain "any statement … regarding
the curative or therapeutic effect… which is false or fraudulent."
This amendment did not
improve drug products but encouraged pharmaceutical companied to be more vague
in their advertisements.
Federal Food, Drug, and
Cosmetic Act
1938
The FDA was given
control over drug safety after 107 people were killed by product produced by a
drug company
Companies now had to file
applications for new drugs with the government that they were safe
They did not have to be
effective
Durham-Humphrey Amendment
1951
Established the criteria
which determine whether a drug is to be classified as prescription or
non-prescription
Durham-Humphrey Amendment
If a drug does not fall
into one of the following categories it is considered nonprescription
The drug is
habit-forming
The drug is not safe for
self-medication due to its toxicity
The drug is new and
lacks safety
Kefauver and Harris
Amendment 1962
Required
Manufactures to
demonstrate effectiveness and safety of drug
Allowed FDA
Withdraw approval of a
drug
Regulate/evaluate drug
testing
New Drugs
All companies must
follow a series of steps when seeking approval to market a new drug
Preclinical research and
development
Clinical research and
development
Permission to market
New Drug: Exceptions
Fast-track rule
Orphan drug law
Drug Advertising
Estimated cost for OTC
drug advertising
Estimated cost for
Prescription drug advertising
The Comprehensive Drug
Abuse Prevention and Control Act of 1970
Divided drugs with abuse
potential into categories:
Schedule I through V
Schedule I
The drug or substance
has high potential for abuse
The drug or substance
has no currently accepted medical use in treatment in the US
There is a lack of
accepted safety for use under medical supervision
Schedule II
The drug or substance
has high potential for abuse
The drug or substance
has a currently accepted medical use in treatment in the US
Abuse of the drug may
lead to severe dependence
Schedule III
The drug or substance
has less of a potential for abuse than in I and II
The drug or substance
has a currently accepted medical use in treatment in the US
Abuse of the drug may
lead to moderate or low dependence
Schedule IV
The drug or substance
has low potential for abuse relative to III
The drug or substance
has a currently accepted medical use in treatment in the US
Abuse of the drug may
lead to limited dependence relative to III
Schedule V
The drug or substance
has low potential for abuse relative to IV
The drug or substance
has a currently accepted medical use in treatment in the US
Abuse of the drug may
lead to limited dependence relative to IV
Federal Trafficking
Penalties
Schedule 1st 2nd
I Not
< 5yr Not< 20
II Not < 5yr Not< 20
III Not > 5yr Not
>10
IV Not > 3yr Not >6
V Not > 1yr Not >2
Supply Reduction
Drug reduction policy
aimed at reducing the supply of illegal drugs and controlling therapeutic drugs
Demand Reduction
Attempts to decrease
individuals tendency to use drugs primarily by reformulating values and
behaviors
Inoculation
A method of abuse
prevention that protects drug users by teaching them responsibility.
Oral Quiz
Can the FDA withdraw
approval of an existing drug?
A drug must go through how
many steps to become approved?
List the categories of
drugs[sched]
What schedule drug is
Marijuana?
Assignment:
Read Chapter #4, Addictive
Behavior and Treating Drug Dependence (16 pgs.)
Be ready for a QUIZ!!!
|